Skip to content

Characterisation of Occupational Allergy to Drosophila

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02535793
Acronym
DROSOALLERG
Enrollment
12
Registered
2015-08-31
Start date
2014-09-30
Completion date
2015-02-28
Last updated
2016-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical Symptoms, Drosophila

Brief summary

Allergy is a very common problem and can be a handicap in everyday life, specially when symptoms occur at work place. Some persons working with drosophila developed respiratory symptoms. Investigators tried to analyze if these manifestations could be due to a specific allergy to drosophila.

Detailed description

To do so, investigators invited laboratory workers who presented any symptoms in presence of drosophila to undergo skin prick tests in order to determine if a specific sensibilization to drosophila exists. Then, a blood sample is taken from these persons to research specific IgE directed against drosophila. By this way, investigators hope determine if a specific allergy to drosophila exists, its characteristics as prevalence, symptoms, populations concerned...in order to better protect laboratory workers and prevent allergy incidence.

Interventions

OTHERblood test (four dry tubes 7ml) and prick tests

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 68 Years
Healthy volunteers
No

Inclusion criteria

* major males or females (aged \<68) who work in laboratory with drosophila in Montpellier (France) * clinical symptoms in presence of drosophila * The subject must be affiliated to a social security scheme * Provision of informed consent prior to any study specific procedures

Exclusion criteria

* The patient has indicated against (or incompatible drug combination) concerning the implementation of a prick test * antihistamine cure in progress * Inability to understand the nature and goals of the study and / or communication difficulties with the investigator * No affiliation to a French social security recipient or not such a scheme * Major protected by law (guardianship, curator or under judicial protection) * deprivation of liberty by judicial or administrative decision * Increased likelihood of non compliance to the protocol or abandonment under study * pregnancy or breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with positive prick test to drosophilaThe day of inclusionPrick tests : measuring the size of the skin reaction (wheal) after prick tests with drosophila. A wheal measuring more than 4 millimeters in diameter sign a sensitization to drosophila. Then, a blood sample is collected in order to measure specific drosophila IgE rate

Secondary

MeasureTime frameDescription
Survey to analyse risk factors for allergy to drosophilaThe day of inclusionanalysis of professional (attended institute, time from start working with drosophila, type of animal manipulation (species, living, dead, DNA, protein) use of protection,) or personal factors (age, gender, others allergies, treatment used) which could lead to allergic reaction to drosophila

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026